Delivery Order SPE2DR25D9239-SPE2DR26FFBY0
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $14,962.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. This firm fixed-price delivery order, awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award...
- The Defense Logistics Agency awarded a $7,481.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra Pen 30 mg/ml. The award, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award...
- The Defense Logistics Agency awarded a $19,950 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award, issued on January 7, 2026, with an ultimate completion date of January 8, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group is performing work at its Park Ridge facility and...
- The Defense Logistics Agency awarded a $4,987.50 firm fixed-price delivery order for FASENRA Pen 30 mg/ml to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on January 9, 2026 with an ultimate completion date of January 12, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $4,987.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The delivery order, issued on January 16, 2026, with an ultimate completion date of January 20, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS...
- The Defense Logistics Agency awarded a $9,975 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. This delivery order, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical...
- The Defense Logistics Agency issued a delivery order valued at $4,987.50 to DMS Pharmaceutical Group Inc. for FASENRA PEN 30 MG/ML on January 15, 2026, with a completion date of January 16, 2026. This firm fixed-price delivery order was awarded without a set-aside designation to the woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. DMS Pharmaceutical Group, which has maintained a System for Award Management registration since 2001, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. This firm fixed-price delivery order, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for FASENRA Pen 30 MG/ML. The award, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,481.25 to DMS Pharmaceutical Group Inc. for FASENRA Pen 30 mg/ml on January 9, 2026, with completion targeted for January 12, 2026. This firm fixed-price delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, that specializes in...
- SPE2DR25D9239Indefinite Delivery Contract
- SPE2DR25D9239-SPE2DR26FFBY0Delivery Order
The Defense Logistics Agency awarded a $4,987.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated consistent performance as a critical supplier within the federal pharmaceutical supply chain, with the PPV-G GEN V IDC featuring a $499.999 billion ceiling value and extending through December 31, 2036. The contract structure comprises a 30-month base period with three 30-month option periods, authorizing the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables. The vendor's extensive product portfolio and established track record of fulfilling diverse pharmaceutical requirements for military healthcare operations position it as a key supplier supporting Department of Defense medical supply needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 1/19/26 |